Drugs / Amivita
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT03103815 | Apr 2017 → Oct 2018 | amyotrophic lateral sclerosis | Wujin People's Hospital | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Amivita | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03103815 ↗ |
| Modality | Other / unclassified | “Amivita, a compound of amino acids and vitamines” NCT03103815 ↗ |
| Route | Intravenous | “Amivita solution (500ml) will be administrated i.v. once daily” NCT03103815 ↗ |